pyrroles has been researched along with Brain Hemorrhage in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Flores, J; Klebe, D; Krafft, PR; Lekic, T; Rolland, WB; Tang, J; Zhang, JH | 2 |
Flores, JJ; Klebe, D; Krafft, PR; Lekic, T; McBride, DW; Rolland, WB; Zhang, JH | 1 |
Goldstein, MR; Mascitelli, L; Pezzetta, F | 1 |
Athyros, VG; Karagiannis, A; Mikhailidis, DP; Tziomalos, K; Wierzbicki, AS | 1 |
Huisa, BN; Stemer, AB; Zivin, JA | 1 |
Molden, E; Westergren, T | 1 |
2 review(s) available for pyrroles and Brain Hemorrhage
Article | Year |
---|---|
Aggressive statin treatment, very low serum cholesterol levels and haemorrhagic stroke: is there an association?
Topics: Anticholesteremic Agents; Atorvastatin; Brain Ischemia; Cholesterol, LDL; Coronary Artery Disease; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Intracranial Hemorrhages; Primary Prevention; Pyrroles; Risk Factors; Secondary Prevention; Stroke | 2010 |
[Interaction risk with statin switch].
Topics: Anticholesteremic Agents; Anticoagulants; Antihypertensive Agents; Aryl Hydrocarbon Hydroxylases; Atorvastatin; Diltiazem; Drug Interactions; Drug Therapy, Combination; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracranial Hemorrhages; Muscular Diseases; Pyrroles; Risk Factors; Simvastatin; Warfarin | 2007 |
5 other study(ies) available for pyrroles and Brain Hemorrhage
Article | Year |
---|---|
Cyclooxygenase-2 Inhibition Provides Lasting Protection Following Germinal Matrix Hemorrhage in Premature Infant Rats.
Topics: Animals; Animals, Newborn; Behavior, Animal; Blotting, Western; Brain; Cyclooxygenase 2; Disease Models, Animal; Intracranial Hemorrhages; Oligopeptides; Pyrroles; Quinazolines; Rats; Rats, Sprague-Dawley; Receptor, PAR-1; Receptors, Thrombin | 2016 |
PAR-1, -4, and the mTOR Pathway Following Germinal Matrix Hemorrhage.
Topics: Animals; Animals, Newborn; Behavior, Animal; Blotting, Western; Brain; Immunosuppressive Agents; Intracranial Hemorrhages; Oligopeptides; Pyrroles; Quinazolines; Rats; Rats, Sprague-Dawley; Receptor, PAR-1; Receptors, Thrombin; Signal Transduction; Sirolimus; Thrombin; TOR Serine-Threonine Kinases | 2016 |
Dabigatran ameliorates post-haemorrhagic hydrocephalus development after germinal matrix haemorrhage in neonatal rat pups.
Topics: Administration, Intranasal; Animals; Animals, Newborn; Antithrombins; Dabigatran; Disease Models, Animal; Extracellular Matrix; Hydrocephalus; Injections, Intraperitoneal; Intracranial Hemorrhages; Maze Learning; Oligopeptides; Pyrroles; Quinazolines; Receptor, PAR-1; Rotarod Performance Test | 2017 |
Hemorrhagic stroke in the SPARCL study.
Topics: Anticholesteremic Agents; Atorvastatin; Female; Heptanoic Acids; Humans; Intracranial Hemorrhages; Lipoproteins, LDL; Male; Pyrroles; Risk Factors; Stroke | 2008 |
Atorvastatin in stroke: a review of SPARCL and subgroup analysis.
Topics: Age Factors; Aged; Atorvastatin; Carotid Artery Diseases; Cholesterol, LDL; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracranial Hemorrhages; Ischemic Attack, Transient; Male; Middle Aged; Pyrroles; Randomized Controlled Trials as Topic; Sex Factors; Stroke; Treatment Outcome | 2010 |